nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—PDE6H—pineal body—malignant glioma	0.047	0.208	CbGeAlD
Sildenafil—PDE6C—retina—malignant glioma	0.024	0.106	CbGeAlD
Sildenafil—Anxiety depression—Temozolomide—malignant glioma	0.0214	0.0486	CcSEcCtD
Sildenafil—PDE6H—retina—malignant glioma	0.0142	0.0627	CbGeAlD
Sildenafil—PDE6G—retina—malignant glioma	0.0136	0.0604	CbGeAlD
Sildenafil—Retinal haemorrhage—Carmustine—malignant glioma	0.0111	0.0253	CcSEcCtD
Sildenafil—PDE5A—endothelium—malignant glioma	0.0111	0.049	CbGeAlD
Sildenafil—PDE5A—blood vessel—malignant glioma	0.0102	0.0452	CbGeAlD
Sildenafil—PDE6H—central nervous system—malignant glioma	0.0074	0.0328	CbGeAlD
Sildenafil—Disorder sight—Temozolomide—malignant glioma	0.00736	0.0167	CcSEcCtD
Sildenafil—Transient ischaemic attack—Temozolomide—malignant glioma	0.00694	0.0158	CcSEcCtD
Sildenafil—Cerebral haemorrhage—Carmustine—malignant glioma	0.00655	0.0149	CcSEcCtD
Sildenafil—Cerebral haemorrhage—Temozolomide—malignant glioma	0.00633	0.0144	CcSEcCtD
Sildenafil—Haemorrhoids—Temozolomide—malignant glioma	0.00596	0.0136	CcSEcCtD
Sildenafil—Visual acuity reduced—Temozolomide—malignant glioma	0.00589	0.0134	CcSEcCtD
Sildenafil—PDE6H—brain—malignant glioma	0.00588	0.026	CbGeAlD
Sildenafil—Myasthenia—Carmustine—malignant glioma	0.00577	0.0131	CcSEcCtD
Sildenafil—ADORA2A—telencephalon—malignant glioma	0.00544	0.0241	CbGeAlD
Sildenafil—Tooth disorder—Temozolomide—malignant glioma	0.0054	0.0123	CcSEcCtD
Sildenafil—PDE5A—retina—malignant glioma	0.00539	0.0239	CbGeAlD
Sildenafil—Burning sensation—Carmustine—malignant glioma	0.00522	0.0119	CcSEcCtD
Sildenafil—PDE5A—telencephalon—malignant glioma	0.00495	0.0219	CbGeAlD
Sildenafil—ABCC5—retina—malignant glioma	0.00493	0.0218	CbGeAlD
Sildenafil—Scotoma—Carmustine—malignant glioma	0.00478	0.0109	CcSEcCtD
Sildenafil—Scotoma—Temozolomide—malignant glioma	0.00461	0.0105	CcSEcCtD
Sildenafil—ABCC5—telencephalon—malignant glioma	0.00453	0.0201	CbGeAlD
Sildenafil—Hyperaesthesia—Temozolomide—malignant glioma	0.00446	0.0102	CcSEcCtD
Sildenafil—Endocrine disorder—Temozolomide—malignant glioma	0.00423	0.00961	CcSEcCtD
Sildenafil—Speech disorder—Carmustine—malignant glioma	0.00422	0.00959	CcSEcCtD
Sildenafil—Accidental injury—Carmustine—malignant glioma	0.0041	0.00932	CcSEcCtD
Sildenafil—Speech disorder—Temozolomide—malignant glioma	0.00407	0.00927	CcSEcCtD
Sildenafil—ADORA2A—spinal cord—malignant glioma	0.00381	0.0169	CbGeAlD
Sildenafil—Herpes simplex—Temozolomide—malignant glioma	0.0038	0.00865	CcSEcCtD
Sildenafil—ABCC10—telencephalon—malignant glioma	0.00379	0.0168	CbGeAlD
Sildenafil—Hearing impaired—Temozolomide—malignant glioma	0.00368	0.00837	CcSEcCtD
Sildenafil—ABCC5—medulla oblongata—malignant glioma	0.00356	0.0158	CbGeAlD
Sildenafil—Musculoskeletal pain—Temozolomide—malignant glioma	0.00355	0.00807	CcSEcCtD
Sildenafil—Urinary incontinence—Carmustine—malignant glioma	0.0035	0.00796	CcSEcCtD
Sildenafil—Neuropathy—Carmustine—malignant glioma	0.0034	0.00774	CcSEcCtD
Sildenafil—Urinary incontinence—Temozolomide—malignant glioma	0.00338	0.0077	CcSEcCtD
Sildenafil—Neuropathy—Temozolomide—malignant glioma	0.00329	0.00748	CcSEcCtD
Sildenafil—ABCC5—midbrain—malignant glioma	0.00325	0.0144	CbGeAlD
Sildenafil—Gynaecomastia—Carmustine—malignant glioma	0.00324	0.00738	CcSEcCtD
Sildenafil—Dry eye—Temozolomide—malignant glioma	0.00324	0.00736	CcSEcCtD
Sildenafil—Abnormal vision—Carmustine—malignant glioma	0.00316	0.00719	CcSEcCtD
Sildenafil—ADORA2A—central nervous system—malignant glioma	0.00309	0.0137	CbGeAlD
Sildenafil—Abnormal vision—Temozolomide—malignant glioma	0.00306	0.00695	CcSEcCtD
Sildenafil—Diabetes mellitus—Carmustine—malignant glioma	0.00303	0.00688	CcSEcCtD
Sildenafil—ADORA2A—cerebellum—malignant glioma	0.00302	0.0134	CbGeAlD
Sildenafil—Swelling—Carmustine—malignant glioma	0.00298	0.00679	CcSEcCtD
Sildenafil—Ear pain—Temozolomide—malignant glioma	0.00298	0.00678	CcSEcCtD
Sildenafil—ABCC10—medulla oblongata—malignant glioma	0.00298	0.0132	CbGeAlD
Sildenafil—Eye pain—Carmustine—malignant glioma	0.00292	0.00663	CcSEcCtD
Sildenafil—Gastroenteritis—Temozolomide—malignant glioma	0.00287	0.00653	CcSEcCtD
Sildenafil—Injury—Carmustine—malignant glioma	0.00286	0.00651	CcSEcCtD
Sildenafil—Deafness—Temozolomide—malignant glioma	0.00284	0.00647	CcSEcCtD
Sildenafil—Eye pain—Temozolomide—malignant glioma	0.00282	0.00641	CcSEcCtD
Sildenafil—PDE5A—central nervous system—malignant glioma	0.00282	0.0125	CbGeAlD
Sildenafil—Nasal congestion—Temozolomide—malignant glioma	0.00279	0.00635	CcSEcCtD
Sildenafil—PDE5A—cerebellum—malignant glioma	0.00275	0.0122	CbGeAlD
Sildenafil—Hot flush—Temozolomide—malignant glioma	0.00272	0.00618	CcSEcCtD
Sildenafil—ABCC10—midbrain—malignant glioma	0.00272	0.012	CbGeAlD
Sildenafil—Dermatitis exfoliative—Temozolomide—malignant glioma	0.0027	0.00613	CcSEcCtD
Sildenafil—Menopausal symptoms—Temozolomide—malignant glioma	0.0027	0.00613	CcSEcCtD
Sildenafil—Thirst—Temozolomide—malignant glioma	0.00267	0.00608	CcSEcCtD
Sildenafil—ABCC10—spinal cord—malignant glioma	0.00265	0.0117	CbGeAlD
Sildenafil—Diplopia—Carmustine—malignant glioma	0.00263	0.00599	CcSEcCtD
Sildenafil—Diplopia—Temozolomide—malignant glioma	0.00254	0.00579	CcSEcCtD
Sildenafil—Face oedema—Carmustine—malignant glioma	0.00254	0.00578	CcSEcCtD
Sildenafil—ABCC5—cerebellum—malignant glioma	0.00252	0.0111	CbGeAlD
Sildenafil—Ataxia—Carmustine—malignant glioma	0.00248	0.00563	CcSEcCtD
Sildenafil—Face oedema—Temozolomide—malignant glioma	0.00246	0.00559	CcSEcCtD
Sildenafil—ADORA2A—brain—malignant glioma	0.00245	0.0109	CbGeAlD
Sildenafil—Liver function test abnormal—Carmustine—malignant glioma	0.00243	0.00553	CcSEcCtD
Sildenafil—Hypokalaemia—Carmustine—malignant glioma	0.0024	0.00545	CcSEcCtD
Sildenafil—Ataxia—Temozolomide—malignant glioma	0.00239	0.00544	CcSEcCtD
Sildenafil—Muscular weakness—Carmustine—malignant glioma	0.00232	0.00528	CcSEcCtD
Sildenafil—Hypokalaemia—Temozolomide—malignant glioma	0.00232	0.00527	CcSEcCtD
Sildenafil—Breast disorder—Temozolomide—malignant glioma	0.0023	0.00523	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00229	0.00521	CcSEcCtD
Sildenafil—Dysphagia—Carmustine—malignant glioma	0.00228	0.00517	CcSEcCtD
Sildenafil—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00224	0.0051	CcSEcCtD
Sildenafil—Muscular weakness—Temozolomide—malignant glioma	0.00224	0.0051	CcSEcCtD
Sildenafil—PDE5A—brain—malignant glioma	0.00224	0.0099	CbGeAlD
Sildenafil—Abdominal distension—Temozolomide—malignant glioma	0.00221	0.00503	CcSEcCtD
Sildenafil—Dysphagia—Temozolomide—malignant glioma	0.0022	0.005	CcSEcCtD
Sildenafil—Bronchitis—Temozolomide—malignant glioma	0.00211	0.00481	CcSEcCtD
Sildenafil—ABCC10—cerebellum—malignant glioma	0.0021	0.00932	CbGeAlD
Sildenafil—Hyperglycaemia—Carmustine—malignant glioma	0.00205	0.00467	CcSEcCtD
Sildenafil—ABCC5—brain—malignant glioma	0.00204	0.00906	CbGeAlD
Sildenafil—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00204	0.00465	CcSEcCtD
Sildenafil—Pneumonia—Carmustine—malignant glioma	0.00204	0.00464	CcSEcCtD
Sildenafil—Pollakiuria—Temozolomide—malignant glioma	0.00203	0.00462	CcSEcCtD
Sildenafil—Erectile dysfunction—Temozolomide—malignant glioma	0.00202	0.00461	CcSEcCtD
Sildenafil—Depression—Carmustine—malignant glioma	0.00202	0.0046	CcSEcCtD
Sildenafil—Photosensitivity reaction—Temozolomide—malignant glioma	0.00201	0.00456	CcSEcCtD
Sildenafil—Weight increased—Temozolomide—malignant glioma	0.002	0.00455	CcSEcCtD
Sildenafil—Renal failure—Carmustine—malignant glioma	0.00199	0.00454	CcSEcCtD
Sildenafil—Neuropathy peripheral—Carmustine—malignant glioma	0.00199	0.00452	CcSEcCtD
Sildenafil—Hyperglycaemia—Temozolomide—malignant glioma	0.00198	0.00451	CcSEcCtD
Sildenafil—Stomatitis—Carmustine—malignant glioma	0.00198	0.0045	CcSEcCtD
Sildenafil—Urinary tract infection—Carmustine—malignant glioma	0.00197	0.00448	CcSEcCtD
Sildenafil—Pneumonia—Temozolomide—malignant glioma	0.00197	0.00448	CcSEcCtD
Sildenafil—Infestation NOS—Temozolomide—malignant glioma	0.00196	0.00446	CcSEcCtD
Sildenafil—Infestation—Temozolomide—malignant glioma	0.00196	0.00446	CcSEcCtD
Sildenafil—Depression—Temozolomide—malignant glioma	0.00195	0.00445	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00194	0.00442	CcSEcCtD
Sildenafil—Neuropathy peripheral—Temozolomide—malignant glioma	0.00192	0.00437	CcSEcCtD
Sildenafil—CYP2E1—telencephalon—malignant glioma	0.00192	0.0085	CbGeAlD
Sildenafil—Stomatitis—Temozolomide—malignant glioma	0.00191	0.00435	CcSEcCtD
Sildenafil—Urinary tract infection—Temozolomide—malignant glioma	0.00191	0.00433	CcSEcCtD
Sildenafil—Sinusitis—Temozolomide—malignant glioma	0.00184	0.00418	CcSEcCtD
Sildenafil—Haemoglobin—Carmustine—malignant glioma	0.00183	0.00416	CcSEcCtD
Sildenafil—Haemorrhage—Carmustine—malignant glioma	0.00182	0.00414	CcSEcCtD
Sildenafil—Hypoaesthesia—Carmustine—malignant glioma	0.00181	0.00412	CcSEcCtD
Sildenafil—Oedema peripheral—Carmustine—malignant glioma	0.00179	0.00408	CcSEcCtD
Sildenafil—Connective tissue disorder—Carmustine—malignant glioma	0.00179	0.00407	CcSEcCtD
Sildenafil—ABCC4—central nervous system—malignant glioma	0.00179	0.00791	CbGeAlD
Sildenafil—Haemoglobin—Temozolomide—malignant glioma	0.00177	0.00402	CcSEcCtD
Sildenafil—Haemorrhage—Temozolomide—malignant glioma	0.00176	0.004	CcSEcCtD
Sildenafil—Visual impairment—Carmustine—malignant glioma	0.00175	0.00399	CcSEcCtD
Sildenafil—Hypoaesthesia—Temozolomide—malignant glioma	0.00175	0.00398	CcSEcCtD
Sildenafil—Pharyngitis—Temozolomide—malignant glioma	0.00175	0.00397	CcSEcCtD
Sildenafil—Urinary tract disorder—Temozolomide—malignant glioma	0.00174	0.00395	CcSEcCtD
Sildenafil—Oedema peripheral—Temozolomide—malignant glioma	0.00173	0.00394	CcSEcCtD
Sildenafil—Connective tissue disorder—Temozolomide—malignant glioma	0.00173	0.00393	CcSEcCtD
Sildenafil—Urethral disorder—Temozolomide—malignant glioma	0.00173	0.00392	CcSEcCtD
Sildenafil—CYP2D6—brainstem—malignant glioma	0.00171	0.00759	CbGeAlD
Sildenafil—ABCC10—brain—malignant glioma	0.00171	0.00757	CbGeAlD
Sildenafil—Eye disorder—Carmustine—malignant glioma	0.0017	0.00387	CcSEcCtD
Sildenafil—Visual impairment—Temozolomide—malignant glioma	0.0017	0.00386	CcSEcCtD
Sildenafil—Flushing—Carmustine—malignant glioma	0.00169	0.00384	CcSEcCtD
Sildenafil—Erythema multiforme—Temozolomide—malignant glioma	0.00166	0.00378	CcSEcCtD
Sildenafil—Eye disorder—Temozolomide—malignant glioma	0.00164	0.00374	CcSEcCtD
Sildenafil—Tinnitus—Temozolomide—malignant glioma	0.00164	0.00373	CcSEcCtD
Sildenafil—Cardiac disorder—Temozolomide—malignant glioma	0.00163	0.00371	CcSEcCtD
Sildenafil—Flushing—Temozolomide—malignant glioma	0.00163	0.00371	CcSEcCtD
Sildenafil—Arrhythmia—Carmustine—malignant glioma	0.00163	0.0037	CcSEcCtD
Sildenafil—Alopecia—Carmustine—malignant glioma	0.00161	0.00366	CcSEcCtD
Sildenafil—Angiopathy—Temozolomide—malignant glioma	0.0016	0.00363	CcSEcCtD
Sildenafil—Mental disorder—Carmustine—malignant glioma	0.0016	0.00363	CcSEcCtD
Sildenafil—Immune system disorder—Temozolomide—malignant glioma	0.00159	0.00362	CcSEcCtD
Sildenafil—Mediastinal disorder—Temozolomide—malignant glioma	0.00159	0.00361	CcSEcCtD
Sildenafil—Erythema—Carmustine—malignant glioma	0.00159	0.00361	CcSEcCtD
Sildenafil—Malnutrition—Carmustine—malignant glioma	0.00159	0.00361	CcSEcCtD
Sildenafil—Chills—Temozolomide—malignant glioma	0.00158	0.00359	CcSEcCtD
Sildenafil—Alopecia—Temozolomide—malignant glioma	0.00156	0.00354	CcSEcCtD
Sildenafil—Mental disorder—Temozolomide—malignant glioma	0.00154	0.00351	CcSEcCtD
Sildenafil—Back pain—Carmustine—malignant glioma	0.00153	0.00349	CcSEcCtD
Sildenafil—Malnutrition—Temozolomide—malignant glioma	0.00153	0.00348	CcSEcCtD
Sildenafil—Erythema—Temozolomide—malignant glioma	0.00153	0.00348	CcSEcCtD
Sildenafil—CYP2D6—telencephalon—malignant glioma	0.00152	0.00673	CbGeAlD
Sildenafil—CYP2E1—medulla oblongata—malignant glioma	0.00151	0.00668	CbGeAlD
Sildenafil—Vision blurred—Carmustine—malignant glioma	0.00149	0.0034	CcSEcCtD
Sildenafil—Tremor—Carmustine—malignant glioma	0.00149	0.00338	CcSEcCtD
Sildenafil—Back pain—Temozolomide—malignant glioma	0.00148	0.00337	CcSEcCtD
Sildenafil—Anaemia—Carmustine—malignant glioma	0.00147	0.00333	CcSEcCtD
Sildenafil—Agitation—Carmustine—malignant glioma	0.00146	0.00331	CcSEcCtD
Sildenafil—Vision blurred—Temozolomide—malignant glioma	0.00144	0.00328	CcSEcCtD
Sildenafil—Tremor—Temozolomide—malignant glioma	0.00144	0.00326	CcSEcCtD
Sildenafil—Ill-defined disorder—Temozolomide—malignant glioma	0.00142	0.00323	CcSEcCtD
Sildenafil—Leukopenia—Carmustine—malignant glioma	0.00142	0.00323	CcSEcCtD
Sildenafil—ABCC4—brain—malignant glioma	0.00142	0.00628	CbGeAlD
Sildenafil—Anaemia—Temozolomide—malignant glioma	0.00142	0.00322	CcSEcCtD
Sildenafil—Agitation—Temozolomide—malignant glioma	0.00141	0.0032	CcSEcCtD
Sildenafil—Malaise—Temozolomide—malignant glioma	0.00138	0.00314	CcSEcCtD
Sildenafil—Vertigo—Temozolomide—malignant glioma	0.00138	0.00313	CcSEcCtD
Sildenafil—Convulsion—Carmustine—malignant glioma	0.00137	0.00312	CcSEcCtD
Sildenafil—Leukopenia—Temozolomide—malignant glioma	0.00137	0.00312	CcSEcCtD
Sildenafil—Hypertension—Carmustine—malignant glioma	0.00137	0.00311	CcSEcCtD
Sildenafil—Palpitations—Temozolomide—malignant glioma	0.00135	0.00308	CcSEcCtD
Sildenafil—Chest pain—Carmustine—malignant glioma	0.00135	0.00307	CcSEcCtD
Sildenafil—Myalgia—Carmustine—malignant glioma	0.00135	0.00307	CcSEcCtD
Sildenafil—CYP2E1—spinal cord—malignant glioma	0.00134	0.00596	CbGeAlD
Sildenafil—Anxiety—Carmustine—malignant glioma	0.00134	0.00306	CcSEcCtD
Sildenafil—Cough—Temozolomide—malignant glioma	0.00134	0.00304	CcSEcCtD
Sildenafil—Convulsion—Temozolomide—malignant glioma	0.00133	0.00302	CcSEcCtD
Sildenafil—Hypertension—Temozolomide—malignant glioma	0.00132	0.00301	CcSEcCtD
Sildenafil—Myalgia—Temozolomide—malignant glioma	0.0013	0.00297	CcSEcCtD
Sildenafil—Arthralgia—Temozolomide—malignant glioma	0.0013	0.00297	CcSEcCtD
Sildenafil—Anxiety—Temozolomide—malignant glioma	0.0013	0.00296	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0013	0.00295	CcSEcCtD
Sildenafil—Oedema—Carmustine—malignant glioma	0.00129	0.00294	CcSEcCtD
Sildenafil—Discomfort—Temozolomide—malignant glioma	0.00129	0.00293	CcSEcCtD
Sildenafil—Infection—Carmustine—malignant glioma	0.00129	0.00292	CcSEcCtD
Sildenafil—Dry mouth—Temozolomide—malignant glioma	0.00128	0.0029	CcSEcCtD
Sildenafil—Tachycardia—Carmustine—malignant glioma	0.00126	0.00287	CcSEcCtD
Sildenafil—Oedema—Temozolomide—malignant glioma	0.00125	0.00284	CcSEcCtD
Sildenafil—Infection—Temozolomide—malignant glioma	0.00124	0.00283	CcSEcCtD
Sildenafil—Anorexia—Carmustine—malignant glioma	0.00123	0.0028	CcSEcCtD
Sildenafil—Nervous system disorder—Temozolomide—malignant glioma	0.00123	0.00279	CcSEcCtD
Sildenafil—Skin disorder—Temozolomide—malignant glioma	0.00121	0.00276	CcSEcCtD
Sildenafil—Hypotension—Carmustine—malignant glioma	0.00121	0.00275	CcSEcCtD
Sildenafil—Hyperhidrosis—Temozolomide—malignant glioma	0.00121	0.00275	CcSEcCtD
Sildenafil—CYP1A1—central nervous system—malignant glioma	0.0012	0.0053	CbGeAlD
Sildenafil—Anorexia—Temozolomide—malignant glioma	0.00119	0.00271	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00118	0.00268	CcSEcCtD
Sildenafil—Insomnia—Carmustine—malignant glioma	0.00117	0.00266	CcSEcCtD
Sildenafil—Paraesthesia—Carmustine—malignant glioma	0.00116	0.00264	CcSEcCtD
Sildenafil—Dyspnoea—Carmustine—malignant glioma	0.00115	0.00262	CcSEcCtD
Sildenafil—Somnolence—Carmustine—malignant glioma	0.00115	0.00262	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00114	0.00259	CcSEcCtD
Sildenafil—Insomnia—Temozolomide—malignant glioma	0.00113	0.00257	CcSEcCtD
Sildenafil—Decreased appetite—Carmustine—malignant glioma	0.00112	0.00256	CcSEcCtD
Sildenafil—Paraesthesia—Temozolomide—malignant glioma	0.00112	0.00255	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Carmustine—malignant glioma	0.00112	0.00254	CcSEcCtD
Sildenafil—Dyspnoea—Temozolomide—malignant glioma	0.00111	0.00254	CcSEcCtD
Sildenafil—Somnolence—Temozolomide—malignant glioma	0.00111	0.00253	CcSEcCtD
Sildenafil—Constipation—Carmustine—malignant glioma	0.00111	0.00252	CcSEcCtD
Sildenafil—Pain—Carmustine—malignant glioma	0.00111	0.00252	CcSEcCtD
Sildenafil—Dyspepsia—Temozolomide—malignant glioma	0.0011	0.0025	CcSEcCtD
Sildenafil—CYP2E1—central nervous system—malignant glioma	0.00109	0.00483	CbGeAlD
Sildenafil—Decreased appetite—Temozolomide—malignant glioma	0.00109	0.00247	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00108	0.00246	CcSEcCtD
Sildenafil—Fatigue—Temozolomide—malignant glioma	0.00108	0.00245	CcSEcCtD
Sildenafil—Pain—Temozolomide—malignant glioma	0.00107	0.00243	CcSEcCtD
Sildenafil—Constipation—Temozolomide—malignant glioma	0.00107	0.00243	CcSEcCtD
Sildenafil—CYP2E1—cerebellum—malignant glioma	0.00107	0.00472	CbGeAlD
Sildenafil—Feeling abnormal—Carmustine—malignant glioma	0.00107	0.00242	CcSEcCtD
Sildenafil—Gastrointestinal pain—Carmustine—malignant glioma	0.00106	0.00241	CcSEcCtD
Sildenafil—Feeling abnormal—Temozolomide—malignant glioma	0.00103	0.00234	CcSEcCtD
Sildenafil—Abdominal pain—Carmustine—malignant glioma	0.00102	0.00233	CcSEcCtD
Sildenafil—Body temperature increased—Carmustine—malignant glioma	0.00102	0.00233	CcSEcCtD
Sildenafil—Gastrointestinal pain—Temozolomide—malignant glioma	0.00102	0.00233	CcSEcCtD
Sildenafil—Urticaria—Temozolomide—malignant glioma	0.000993	0.00226	CcSEcCtD
Sildenafil—Abdominal pain—Temozolomide—malignant glioma	0.000988	0.00225	CcSEcCtD
Sildenafil—Body temperature increased—Temozolomide—malignant glioma	0.000988	0.00225	CcSEcCtD
Sildenafil—Hypersensitivity—Carmustine—malignant glioma	0.000953	0.00217	CcSEcCtD
Sildenafil—CYP1A1—brain—malignant glioma	0.00095	0.00421	CbGeAlD
Sildenafil—Asthenia—Carmustine—malignant glioma	0.000928	0.00211	CcSEcCtD
Sildenafil—Hypersensitivity—Temozolomide—malignant glioma	0.000921	0.0021	CcSEcCtD
Sildenafil—Asthenia—Temozolomide—malignant glioma	0.000897	0.00204	CcSEcCtD
Sildenafil—Diarrhoea—Carmustine—malignant glioma	0.000885	0.00201	CcSEcCtD
Sildenafil—Pruritus—Temozolomide—malignant glioma	0.000885	0.00201	CcSEcCtD
Sildenafil—CYP3A4—central nervous system—malignant glioma	0.000878	0.00389	CbGeAlD
Sildenafil—CYP2E1—brain—malignant glioma	0.000866	0.00384	CbGeAlD
Sildenafil—CYP2D6—central nervous system—malignant glioma	0.000864	0.00383	CbGeAlD
Sildenafil—Dizziness—Carmustine—malignant glioma	0.000856	0.00195	CcSEcCtD
Sildenafil—Diarrhoea—Temozolomide—malignant glioma	0.000855	0.00195	CcSEcCtD
Sildenafil—CYP2D6—cerebellum—malignant glioma	0.000844	0.00374	CbGeAlD
Sildenafil—Dizziness—Temozolomide—malignant glioma	0.000827	0.00188	CcSEcCtD
Sildenafil—Vomiting—Carmustine—malignant glioma	0.000823	0.00187	CcSEcCtD
Sildenafil—Rash—Carmustine—malignant glioma	0.000816	0.00186	CcSEcCtD
Sildenafil—Dermatitis—Carmustine—malignant glioma	0.000815	0.00185	CcSEcCtD
Sildenafil—Headache—Carmustine—malignant glioma	0.00081	0.00184	CcSEcCtD
Sildenafil—Vomiting—Temozolomide—malignant glioma	0.000795	0.00181	CcSEcCtD
Sildenafil—Rash—Temozolomide—malignant glioma	0.000788	0.00179	CcSEcCtD
Sildenafil—Dermatitis—Temozolomide—malignant glioma	0.000788	0.00179	CcSEcCtD
Sildenafil—Headache—Temozolomide—malignant glioma	0.000783	0.00178	CcSEcCtD
Sildenafil—Nausea—Carmustine—malignant glioma	0.000768	0.00175	CcSEcCtD
Sildenafil—Nausea—Temozolomide—malignant glioma	0.000743	0.00169	CcSEcCtD
Sildenafil—CYP2D6—brain—malignant glioma	0.000686	0.00304	CbGeAlD
Sildenafil—ABCC5—Disease—PTGS2—malignant glioma	5.76e-05	0.000172	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—IDH2—malignant glioma	5.74e-05	0.000171	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP2C18—malignant glioma	5.71e-05	0.000171	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HES1—malignant glioma	5.69e-05	0.00017	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NCOR1—malignant glioma	5.65e-05	0.000169	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CD—malignant glioma	5.58e-05	0.000167	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—RAF1—malignant glioma	5.58e-05	0.000167	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—KRAS—malignant glioma	5.52e-05	0.000165	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—IL2—malignant glioma	5.51e-05	0.000165	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PIK3CB—malignant glioma	5.45e-05	0.000163	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PDGFRA—malignant glioma	5.41e-05	0.000162	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MYC—malignant glioma	5.41e-05	0.000162	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.41e-05	0.000162	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP2B6—malignant glioma	5.39e-05	0.000161	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.39e-05	0.000161	CbGpPWpGaD
Sildenafil—PDE6G—Disease—AKT1—malignant glioma	5.36e-05	0.00016	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—COX8A—malignant glioma	5.35e-05	0.00016	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—EGFR—malignant glioma	5.29e-05	0.000158	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—IDH2—malignant glioma	5.28e-05	0.000158	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SPP1—malignant glioma	5.26e-05	0.000157	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CXCL8—malignant glioma	5.23e-05	0.000156	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—IDH2—malignant glioma	5.23e-05	0.000156	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—PIK3CA—malignant glioma	5.07e-05	0.000152	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PTEN—malignant glioma	5.02e-05	0.00015	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—IL2—malignant glioma	5e-05	0.000149	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—KRAS—malignant glioma	5e-05	0.000149	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TERT—malignant glioma	4.98e-05	0.000149	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP2B6—malignant glioma	4.96e-05	0.000148	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—IDH1—malignant glioma	4.93e-05	0.000147	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.93e-05	0.000147	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP2B6—malignant glioma	4.92e-05	0.000147	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.91e-05	0.000147	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TP53—malignant glioma	4.91e-05	0.000147	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTT1—malignant glioma	4.9e-05	0.000146	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTT1—malignant glioma	4.89e-05	0.000146	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CB—malignant glioma	4.87e-05	0.000145	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PDGFB—malignant glioma	4.86e-05	0.000145	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—FGFR1—malignant glioma	4.84e-05	0.000145	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTGS2—malignant glioma	4.82e-05	0.000144	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SPHK1—malignant glioma	4.77e-05	0.000143	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HIF1A—malignant glioma	4.77e-05	0.000142	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.74e-05	0.000142	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GSTP1—malignant glioma	4.69e-05	0.00014	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP2C18—malignant glioma	4.68e-05	0.00014	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTT1—malignant glioma	4.62e-05	0.000138	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CAV1—malignant glioma	4.61e-05	0.000138	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PIK3CA—malignant glioma	4.59e-05	0.000137	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTGS1—malignant glioma	4.59e-05	0.000137	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTGS1—malignant glioma	4.58e-05	0.000137	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CAT—malignant glioma	4.56e-05	0.000136	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KDR—malignant glioma	4.56e-05	0.000136	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ASMT—malignant glioma	4.55e-05	0.000136	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—IDH1—malignant glioma	4.54e-05	0.000136	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—IDH1—malignant glioma	4.5e-05	0.000134	CbGpPWpGaD
Sildenafil—ABCC5—Disease—STAT3—malignant glioma	4.49e-05	0.000134	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TP53—malignant glioma	4.44e-05	0.000133	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.41e-05	0.000132	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SPHK1—malignant glioma	4.39e-05	0.000131	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—F2—malignant glioma	4.39e-05	0.000131	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—FN1—malignant glioma	4.39e-05	0.000131	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SPHK1—malignant glioma	4.35e-05	0.00013	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—BAD—malignant glioma	4.34e-05	0.00013	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTGS1—malignant glioma	4.33e-05	0.000129	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.31e-05	0.000129	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—NCOR1—malignant glioma	4.31e-05	0.000129	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP2C18—malignant glioma	4.3e-05	0.000129	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NOTCH1—malignant glioma	4.29e-05	0.000128	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—BCAN—malignant glioma	4.28e-05	0.000128	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—BCHE—malignant glioma	4.27e-05	0.000128	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP2C18—malignant glioma	4.26e-05	0.000127	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—BCHE—malignant glioma	4.26e-05	0.000127	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SLC5A5—malignant glioma	4.22e-05	0.000126	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SLC5A5—malignant glioma	4.21e-05	0.000126	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CD80—malignant glioma	4.21e-05	0.000126	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTEN—malignant glioma	4.21e-05	0.000126	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CG—malignant glioma	4.2e-05	0.000125	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—APC—malignant glioma	4.2e-05	0.000125	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MYC—malignant glioma	4.17e-05	0.000125	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EGF—malignant glioma	4.15e-05	0.000124	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—AKT1—malignant glioma	4.14e-05	0.000124	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PTPN11—malignant glioma	4.12e-05	0.000123	CbGpPWpGaD
Sildenafil—ABCC5—Disease—EGFR—malignant glioma	4.08e-05	0.000122	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—BCHE—malignant glioma	4.03e-05	0.00012	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.02e-05	0.00012	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.02e-05	0.00012	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SLC5A5—malignant glioma	3.98e-05	0.000119	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—BRAF—malignant glioma	3.95e-05	0.000118	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.88e-05	0.000116	CbGpPWpGaD
Sildenafil—ABCC5—Disease—KRAS—malignant glioma	3.86e-05	0.000115	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AKT2—malignant glioma	3.84e-05	0.000115	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—EGFR—malignant glioma	3.83e-05	0.000114	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTT1—malignant glioma	3.78e-05	0.000113	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.76e-05	0.000112	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—AKT1—malignant glioma	3.75e-05	0.000112	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.73e-05	0.000111	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CD—malignant glioma	3.69e-05	0.00011	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.66e-05	0.000109	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—PIK3CA—malignant glioma	3.66e-05	0.000109	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—KRAS—malignant glioma	3.61e-05	0.000108	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTGS1—malignant glioma	3.54e-05	0.000106	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PIK3CA—malignant glioma	3.54e-05	0.000106	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.53e-05	0.000106	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—FGF2—malignant glioma	3.53e-05	0.000106	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.53e-05	0.000106	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CAV1—malignant glioma	3.51e-05	0.000105	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTT1—malignant glioma	3.48e-05	0.000104	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—IDH2—malignant glioma	3.45e-05	0.000103	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTT1—malignant glioma	3.45e-05	0.000103	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTP1—malignant glioma	3.4e-05	0.000102	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTP1—malignant glioma	3.39e-05	0.000101	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PIK3CA—malignant glioma	3.32e-05	9.92e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MDM2—malignant glioma	3.31e-05	9.88e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CAT—malignant glioma	3.31e-05	9.88e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CAT—malignant glioma	3.3e-05	9.86e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—RAF1—malignant glioma	3.3e-05	9.85e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—BCHE—malignant glioma	3.29e-05	9.85e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ERBB2—malignant glioma	3.26e-05	9.74e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTGS1—malignant glioma	3.26e-05	9.74e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SLC5A5—malignant glioma	3.25e-05	9.73e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.25e-05	9.71e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.24e-05	9.69e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTGS1—malignant glioma	3.23e-05	9.66e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.22e-05	9.62e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CB—malignant glioma	3.22e-05	9.62e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTP1—malignant glioma	3.2e-05	9.57e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CG—malignant glioma	3.2e-05	9.57e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—NCOR1—malignant glioma	3.12e-05	9.33e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CAT—malignant glioma	3.12e-05	9.32e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—NCOR1—malignant glioma	3.12e-05	9.31e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CXCL8—malignant glioma	3.09e-05	9.24e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PPARG—malignant glioma	3.09e-05	9.23e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.08e-05	9.2e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.05e-05	9.11e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—BCHE—malignant glioma	3.03e-05	9.06e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—BCHE—malignant glioma	3e-05	8.98e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SLC5A5—malignant glioma	2.99e-05	8.95e-05	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—AKT1—malignant glioma	2.99e-05	8.93e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CA—malignant glioma	2.97e-05	8.87e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SLC5A5—malignant glioma	2.97e-05	8.87e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—IDH1—malignant glioma	2.97e-05	8.86e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CASP3—malignant glioma	2.96e-05	8.84e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL2—malignant glioma	2.95e-05	8.83e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—NCOR1—malignant glioma	2.94e-05	8.8e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—AKT1—malignant glioma	2.89e-05	8.65e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SPHK1—malignant glioma	2.87e-05	8.58e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CD—malignant glioma	2.81e-05	8.41e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.81e-05	8.4e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.81e-05	8.39e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MMP9—malignant glioma	2.8e-05	8.36e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.78e-05	8.31e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PTEN—malignant glioma	2.78e-05	8.31e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—AKT1—malignant glioma	2.71e-05	8.11e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.66e-05	7.95e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTP1—malignant glioma	2.62e-05	7.83e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CAT—malignant glioma	2.55e-05	7.62e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CAV1—malignant glioma	2.54e-05	7.61e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CAV1—malignant glioma	2.54e-05	7.59e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VEGFA—malignant glioma	2.51e-05	7.51e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—STAT3—malignant glioma	2.49e-05	7.43e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CB—malignant glioma	2.45e-05	7.33e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTGS2—malignant glioma	2.43e-05	7.26e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.42e-05	7.25e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—AKT1—malignant glioma	2.42e-05	7.24e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTP1—malignant glioma	2.41e-05	7.21e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—NCOR1—malignant glioma	2.41e-05	7.2e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CAV1—malignant glioma	2.4e-05	7.17e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTP1—malignant glioma	2.39e-05	7.14e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CAT—malignant glioma	2.35e-05	7.01e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CAT—malignant glioma	2.33e-05	6.95e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CG—malignant glioma	2.32e-05	6.93e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CG—malignant glioma	2.31e-05	6.91e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MYC—malignant glioma	2.31e-05	6.91e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.29e-05	6.85e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTT1—malignant glioma	2.27e-05	6.8e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EGFR—malignant glioma	2.26e-05	6.75e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PPARG—malignant glioma	2.24e-05	6.69e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PPARG—malignant glioma	2.23e-05	6.67e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NCOR1—malignant glioma	2.22e-05	6.62e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NCOR1—malignant glioma	2.2e-05	6.56e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CG—malignant glioma	2.19e-05	6.53e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KRAS—malignant glioma	2.13e-05	6.38e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS1—malignant glioma	2.13e-05	6.37e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTEN—malignant glioma	2.12e-05	6.33e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PPARG—malignant glioma	2.11e-05	6.3e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CD—malignant glioma	2.04e-05	6.09e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CD—malignant glioma	2.03e-05	6.08e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—BCHE—malignant glioma	1.98e-05	5.92e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CAV1—malignant glioma	1.96e-05	5.87e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CA—malignant glioma	1.96e-05	5.86e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.96e-05	5.85e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CD—malignant glioma	1.92e-05	5.74e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—malignant glioma	1.9e-05	5.67e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.88e-05	5.61e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CAV1—malignant glioma	1.81e-05	5.4e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CAV1—malignant glioma	1.79e-05	5.35e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CG—malignant glioma	1.79e-05	5.35e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CB—malignant glioma	1.78e-05	5.31e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.77e-05	5.3e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTGS2—malignant glioma	1.76e-05	5.26e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTGS2—malignant glioma	1.76e-05	5.25e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PPARG—malignant glioma	1.73e-05	5.16e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.71e-05	5.11e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CB—malignant glioma	1.67e-05	5.01e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTGS2—malignant glioma	1.66e-05	4.96e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.64e-05	4.92e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.63e-05	4.87e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AKT1—malignant glioma	1.6e-05	4.79e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PPARG—malignant glioma	1.59e-05	4.75e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTP1—malignant glioma	1.58e-05	4.71e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PPARG—malignant glioma	1.57e-05	4.7e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.57e-05	4.7e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTEN—malignant glioma	1.53e-05	4.59e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CAT—malignant glioma	1.53e-05	4.58e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTEN—malignant glioma	1.53e-05	4.58e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CA—malignant glioma	1.49e-05	4.47e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NCOR1—malignant glioma	1.45e-05	4.33e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTEN—malignant glioma	1.45e-05	4.33e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.45e-05	4.32e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.43e-05	4.29e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.37e-05	4.1e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTGS2—malignant glioma	1.36e-05	4.06e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.26e-05	3.77e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.25e-05	3.73e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTGS2—malignant glioma	1.25e-05	3.73e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTGS2—malignant glioma	1.24e-05	3.7e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AKT1—malignant glioma	1.22e-05	3.65e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTEN—malignant glioma	1.18e-05	3.54e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CAV1—malignant glioma	1.18e-05	3.53e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTEN—malignant glioma	1.09e-05	3.26e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CA—malignant glioma	1.08e-05	3.24e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.08e-05	3.23e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTEN—malignant glioma	1.08e-05	3.23e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.08e-05	3.21e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PPARG—malignant glioma	1.04e-05	3.1e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CA—malignant glioma	1.02e-05	3.05e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CD—malignant glioma	9.45e-06	2.83e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKT1—malignant glioma	8.85e-06	2.64e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKT1—malignant glioma	8.83e-06	2.64e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CA—malignant glioma	8.35e-06	2.5e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKT1—malignant glioma	8.34e-06	2.49e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CB—malignant glioma	8.24e-06	2.46e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS2—malignant glioma	8.17e-06	2.44e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CA—malignant glioma	7.68e-06	2.3e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CA—malignant glioma	7.62e-06	2.28e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTEN—malignant glioma	7.12e-06	2.13e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKT1—malignant glioma	6.82e-06	2.04e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKT1—malignant glioma	6.28e-06	1.88e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKT1—malignant glioma	6.22e-06	1.86e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CA—malignant glioma	5.02e-06	1.5e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKT1—malignant glioma	4.1e-06	1.23e-05	CbGpPWpGaD
